The offer of free RSV vaccination for pregnant women will be brought forward from spring 2026 to autumn 2025, according to a press release. The government expects the vaccination program to be effective around October 1st.

The government has allocated DKK 35.9 million in 2026 and DKK 40.2 million in 2027 and onwards for the program, with an additional DKK 18.9 million expected to cover the costs of advancing the vaccination program to 2025.

Pregnant women will be offered the vaccine during their 32nd week pregnancy examination, with vaccination possible up to and including the 36th week.

The Danish Health Authority recommended vaccinating pregnant women against RSV in May, and the Ministry of the Interior and Health has followed this recommendation. The authority anticipates that vaccinating pregnant women can prevent a significant number of severe cases and hospitalizations among children by transferring protective antibodies from the mother to the infant.

Interior and Health Minister Sophie Løhde hopes that the vaccination program will prevent hospitalizations during the coming winter, when many children are typically infected.

Over the past decade, approximately 1300 children under one year old have been hospitalized annually due to RSV infection, with about one-third requiring intensive care.

The Danish Health Authority also recommends that pregnant women be vaccinated against COVID-19, influenza, and whooping cough.